Currently, high field (1.5 T) superconducting MR imaging does not allow live guidance during needle breast procedures. The current procedure allows the physician only to calculate approximately the location and extent of a cancerous tumor in the compressed patient breast before inserting the needle. It can then become relatively uncertain that the tissue specimen removed during the biopsy actually belongs to the lesion of interest. A new method for guiding clinical breast biopsy is presented, based on a deformable finite element model of the breast. The geometry of the model is constructed from MR data, and its mechanical properties are modeled using a non-linear material model. This method allows imaging the breast without or with mild compression before the procedure, then compressing the breast and using the finite element model to predict the tumor's position during the procedure. A silicon phantom containing a stiff inclusion was imaged uncompressed then compressed. A model of the phantom was constructed and compressed using custom-written software, and also using a commercial FEM simulation package. The displacement of the inclusion's corners was recorded both in the real phantom and in the two compressed models. A patient's breast was imaged uncompressed then compressed. A deformable model of the uncompressed breast was constructed, then compressed. The displacement of a cyst and of two vitamin E pills taped to the surface of the breast were recorded both in the real and in the modeled breast. The entire procedure lasted less than a half-hour, making it clinically useful. The results show that it is possible to create a deformable model of the breast based on finite elements with non-linear material properties, capable of modeling and predicting breast deformations in a clinically useful amount of time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s1361-8415(01)00053-6 | DOI Listing |
Curr Med Chem
January 2025
Laboratory of Pharmaceutical Biotechnology and Bioinformatics, Department of Genetic Engineering and Biotechnology, Jashore University of Science and Technology, Jashore, 7408, Bangladesh.
Background: Breast cancer is a frequently diagnosed malignant disease and the primary cause of mortality among women with cancer worldwide. The therapy options are influenced by the molecular subtype due to the intricate nature of the condition, which consists of various subtypes. By focusing on the activation of receptors, Epidermal Growth Factor Receptor (EGFR) tyrosine kinase can be utilized as an effective drug target for therapeutic purposes of breast cancer.
View Article and Find Full Text PDFWorld J Gastrointest Oncol
January 2025
Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China.
Background: Red blood cell distribution width (RDW) is associated with the development and progression of various diseases.
Aim: To explore the association between pretreatment RDW and short-term outcomes after laparoscopic pancreatoduodenectomy (LPD).
Methods: A total of 804 consecutive patients who underwent LPD at our hospital between March 2017 and November 2021 were retrospectively analyzed.
Pain Rep
February 2025
Department of Anaesthesia, Surgical Critical Care and Pain Management, National Cancer Institute-Cairo University, Cairo, Egypt.
Introduction: Management of pain associated with breast cancer surgeries is crucial in reducing incidence of postmastectomy pain syndrome. The pain distribution involves the anterior chest wall, axillary area and ipsilateral upper limb.
Objective: This study was designed to investigate the effect of bilevel erector spinae plane block (ESPB) with high thoracic block vs the conventional unilevel ESPB vs opioids in patients with cancer undergoing modified radical mastectomy regarding pain control and reducing pain in axilla.
Surg Open Sci
January 2025
Division of Breast Cancer Surgery, Department of Surgery, National Cancer Institute, Bangkok, Thailand.
Background: Breast cancer is the most common cancer among women. In response to the need to hospital stays and minimize waiting time for surgery, particularly during the COVID-19 pandemic, the National Cancer Institute developed the One Day Surgery with Breast cancer Home Recovery program (ODS BHR NCI). The aim of study is to assess the success rate of breast cancer surgeries conducted through this program and to evaluate the incidence of complications.
View Article and Find Full Text PDFTheranostics
January 2025
Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361102, China.
Immunogenic cell death (ICD) offers a promising avenue for the treatment of triple-negative breast cancer (TNBC). However, optimizing immune responses remains a formidable challenge. This study presents the design of RBCm@Pt-CoNi layered double hydroxide (RmPLH), an innovative sonosensitizer for sonodynamic therapy (SDT), aimed at enhancing the efficacy of programmed cell death protein 1 (PD-1) inhibitors by inducing robust ICD responses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!